News

STAT1h
Questions about the FDA’s ‘radical transparency’ efforts
Happy Friday. Today, we talk about the stem cell fire sale at CIRM, and about the FDA’s move to release a limited batch of ...
Fierce Biotech48m
FDA rejects Capricor’s DMD cell therapy, asks for more data
The FDA has rejected Capricor Therapeutics’ filing for approval of a Duchenne muscular dystrophy (DMD) cell therapy, raising ...
BioSpace11d
FDA’s AI Rollout Raises Questions Around Readiness, Legality
The FDA’s clunky launch of Elsa, an AI tool to increase efficiency, has sparked concern from agency employees and outside ...
STAT18h
NIH grant cuts, FDA transparency questions, and biotech M&A
On this week's episode of "The Readout LOUD": a closer look at the NIH’s grant-cutting legal playbook, FDA transparency ...
FDA to "review the latest data" on mifepristone. What could it mean for access to the abortion pill?
HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone​," but experts say concerns ...
Hosted on MSN4mon
FDA nominee sidesteps questions on abortion pill, agency layoffs ... - MSN
President Donald Trump’s pick to lead the Food and Drug Administration largely sidestepped questions Thursday from senators about how he would handle numerous pressing issues before the agency ...
Los Angeles Times2y
FDA questions proposal to make birth control pill available over the ...
FDA questions proposal to make birth control pill available over the counter. Advisors to the Food and Drug Administration will meet next week to review drugmaker Perrigo’s application to sell ...
Forbes2y
‘F In FDA’ Trends After Questions About Pink Sauce Emerge ... - Forbes
The phrase “F in FDA” trended on Twitter on Monday after Chef Pii responded to questions about ...More whether her Pink Sauce was approved by the U.S. Food and Drug Administration (FDA ...
NPR6y
FDA Questions Safety And Marketing Of Cannabidiol, Known As CBD
The FDA holds a hearing Friday on CBD, a popular extract of the cannabis plant. The FDA sent warning letters to companies about illegal marketing practices, and says it needs more data about ...
The Washington Post1mon
FDA to issue new vaccine approval guidance amid questions over ...
FDA to issue new vaccine approval guidance amid questions over coronavirus shots. FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming ...
FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say
Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...